Alkermes Competitors and Similar CompaniesClear all
Alkermes's competitors and similar companies include UCB, EMS Pharma, Cipla and Livzon Pharmaceutical Group.
 Alkermes Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system diseases. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | |
Founding Date | Founding Date 1987 | Founding Date 1928 | Founding Date 1964 | Founding Date 1935 | Founding Date 1985 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Dublin, IE HQ Westmeath, IE Waltham, US Wilmington, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations BR HQ | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 1,800 | Employees 9,052 | Employees 12,7441% increase | Employees 27,764 | Employees 9,067 |
Valuation ($) | Valuation ($) 4.3 b | Valuation ($) 34.3 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.5b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods $196.5m (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A | Cost of goods ₹95.5b (FY, 2026) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit $1.3b (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit N/A | Gross profit ₹195b (FY, 2026) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income $241.7m (FY, 2025) | Net income €1.6b (FY, 2025) | Net income N/A | Net income ₹38.7b (FY, 2026) | Net income ¥2.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyEMS Pharma
HQ
BR
Employees
12,744↑ 1% increase
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company